Dr. Bishayee is the Director of Research and Professor of Pharmacology at the Lake Erie College of Osteopathic Medicine (Bradenton, Florida). Dr. Bishayee has more than 25 years combined experience in pharmaceutical and biomedical education, research, teaching, and administration. He received his Bachelor of Pharmacy (B.Pharm.), Master of Pharmacy (M.Pharm.), and Ph.D. (cancer prevention) from Jadavpur University, Kolkata, India. Dr. Bishayee performed post-doctoral research at Rutgers University, Newark, New Jersey (formerly University of Medicine and Dentistry of New Jersey) and completed a fellowship in Academic Medicine from Northeast Ohio Medical University (NEOMED, Rootstown, Ohio). Dr. Bishayee’s primary research interest during last two decades encompasses natural products and dietary agents in health and disease. His laboratory is involved in investigating cancer preventive and therapeutic effects of medicinal plants, natural products, dietary and synthetic agents using various pre-clinical models of cancer and underlying mechanisms of action. The various projects of Dr. Bishayee are funded by the National Institutes of Health as well as private pharmaceutical and biotechnological companies. Dr Bishayee has been awarded a United States patent on development of a potential drug for breast cancer prevention and treatment. Dr. Bishayee has published more than 300 peer-reviewed original research papers and authoritative review articles, mostly in high-impact journals, including Nature Reviews Drug Discovery [impact factor (IF) 120.1], Biotechnology Advances (IF 16.0), Trends in Food Science and Technology (IF 15.3), Seminars in Cancer Biology (IF 14.5), Acta Pharmaceutica Sinica B (IF 14.5), Pharmacology and Therapeutics (IF 13.5), Medicinal Research Reviews (IF 13.3), Cancer Treatment Reviews (IF 11.8), Critical Reviews in Food Science and Nutrition (IF 10.2), Biochimica et Biophysica Acta - Reviews on Cancer (IF 11.2), Clinical and Translational Medicine (IF 10.6), Cancer Letters (IF 9.7), Advances in Nutrition (IF 9.3), Cancer and Metastasis Reviews (IF 9.3), and Pharmacological Research (IF 9.3); 22 book chapters; and around 90 conference abstracts, and delivered more than 30 invited presentations at various national and international scientific meetings. Dr. Bishayee is an editorial board member of various reputed journals, such as Pharmacological Research, Phytomedicine (Elsevier), Frontiers in Oncology (Frontiers Media S.A.), Frontiers in Pharmacology, Cancers (MDPI), BMC Complementary and Alternative Medicine (Springer Nature), Current Molecular Pharmacology (Bentham Science), and Anti-Cancer Drugs (Wolters Kluwer) and reviewer of more than 80 reputed journals. Dr. Bishayee edited an Elsevier book “Epigenetics of Cancer Prevention” and guest edited several special issues on natural products and cancer published by leading publishers, such as Elsevier, Springer Nature, MDPI, and Bentham. Dr. Bishayee is a “Highly Cited Researcher” in 2022 and his papers rank in the top 1% by citations for a field or fields (Clarivate, Web of Science). His Scopus h-index is 75 and scholars from all over the world have cited Dr. Bishayee’s published work more than 25,000 times.

Jingwei Xie received his B.S. (1999) and M.S. (2002) from Nanjing University of Technology, China, and his Ph.D. from the National University of Singapore (2007). He worked as a postdoctoral fellow in the Xia group at Washington University in St. Louis (2007‐2010). He is currently a Professor in the Department of Surgery-Transplant and Holland Regenerative Medicine Program at the University of Nebraska Medical Center (UNMC). He has won several prestigious awards including Most Promising New Invention Award at UNMC (2017), Maurer Scientific Achievement Award (2019), CAB Mid-Career Investigator Award (2020), and Distinguished Scientist Award at UNMC (2021). He was recently selected as 2024 AIMBE Fellow. His research interests include biomaterials, drug delivery, wound healing, hemostasis, and regenerative medicine.

Paula Ferreira is a Coordinator Researcher at the University of Aveiro, CICECO – Aveiro Institute of Materials. She has been Principal and Co- Investigator on more than 16 research project awards and 10 projects with industry. She has a vast experience as a supervisor, with 33 MSc students (currently 3), 16 PhD students (currently 10) and 12 Post-doctoral fellows. Her publishing history counts over 200 scientific papers, with over 3223 citations (h-index 33). She participated in over 110 international conferences delivering more than 60 oral presentations. She is/was involved in 4 FCT-CNRS and 1 Pessoa bilateral cooperation agreements and 10 COST actions (5 as participant of the working groups and 5 as member of the management committee). She has been collaborating with several Portuguese Researchers and foreigner Researchers within Europe. She participated on the organizing committee of 9 International Scientific Meetings on Materials Science topics.

The research interests involve the synthesis, structural and physical characterization, and processing of nanofunctional and nanoporous materials for microelectronics and energy applications by bottom-up approaches. She is also interested in sustainable functional bionanocomposites for flexible devices application.

Susana Olhero is nowadays Assistant Professor and member of the Executive Board of the Department of Materials and Ceramics Engineering (DEMaC)/University of Aveiro, and a research member of CICECO - Aveiro Institute of Materials. The focus of her research has been the development of 3D structures by near net shaping colloidal-based techniques, including additive manufacturing of various functional ceramics for several applications, including bio-implants. Her knowledge and experience in this area has been consolidated by several indicators including publications, projects and supervisions.

Dr. Michele Bianchi completed his Ph.D. in Chemical Sciences in 2011 at the “Alma Mater Studiorum” University of Bologna, Italy. In 2012 he was a Visiting Researcher in the biomaterial group of Prof. John Jansen (Radboud University Medical Center, Nijmegen, The Netherlands). Until 2018 he was Research Associate at the Rizzoli Orthopedic Institute (Bologna, Italy), then he was Researcher at the Italian Institute of Technology (Ferrara, Italy) up to 2022. The same year he was appointed Assistant Professor at the University of Modena and Reggio Emilia, where he is currently in charge of General Chemistry and Advanced Biomaterials teachings. His research focuses on the investigation of cell migration and differentiation in microstructured environments under the application of external stimuli such as electrical and mechanical ones. He has published more than 70 peer-reviewed publications in the biomaterials/bioelectronics field and his work has been presented at more than 60 national and international conferences, including several invited talks. He is also inventor of 3 patents and co-founder of the start-up company “Organic Bioelectronics”. He is currently member of the Early Career Editorial Board of “Bioactive Materials” (KeAi). He has been responsible for several nationally and European funded projects dealing with biomaterials and cell interfaces for regenerative medicine.

Filomena Freitas is an Assistant Professor at the Chemistry Department of NOVA School of Sciences and Technology, NOVA University Lisbon (FCT NOVA), Portugal, and a Senior Researcher at the Biochemical Engineering Group (BIOENG), at UCIBIO, FCT NOVA. She has completed a PhD in Biological Engineering by  FCT NOVA in 2004. She has developed research on the development of upstream and downstream processes for the production of value-added microbial products, including polysaccharides and polyhydroxyalkanoates, as well as intellectual property development and technology transfer. Special focus is also given on the biological valorization of agro-industrial wastes/byproducts, aiming at implementing sustainable bioprocesses. She has over 110 papers published in international peer review journals, book chapters and International Patents, which have recently been granted in several countries.

Monica Sandri is Research Director at the National Research Council of Italy (CNR), Institute of Science, Technology and Sustainability for Ceramics (ISSMC, ex ISTEC), with expertise on the design and development of ceramic, polymeric and hybrid biomaterials as biomatrices mimetic of the native ECMs, and suitable for tissue regeneration, for the development of in vitro organoids for the discovery of personalized therapies. Coordinator of the research activity aimed at the study of biomineralization processes to produce biomimetic nanostructured hybrid and polymer hydrogels and bioinks processable by 3D-printing technologies, finalized at the development of three-dimensional scaffolds for tissues regeneration (bone, tooth, cartilage, skin tissues) with geometry, porosity and structural and mechanical properties customized by means of 3D printing and mold-freeze-casting techniques. Development of biomimetic and medicated membranes for chronic wound management capable of simultaneously fighting infections and guiding tissue healing and regeneration. Design and development of biomatrices for 3D in vitro predictive models, through 3D bioprinting and co-cultures approaches, aimed at the study of personalized targeted pharmacological therapies in the field of tumor and infectious diseases (e.g. investigation or osteosarcoma, leukemia, osteomyelitis). Scientific responsible for many funded European Projects, Coordinator of National, Regional and PNRR Research Projects. Graduated in Chemistry in 2001 from the Alma Mater Studiorum, University of Bologna, Italy and obtained the PhD degree in Material Science in 2006. She has authored 148 papers published in international peer-reviewed journals, 13 book chapters and 4 Patents. H-index = 43, total citations > 6336.

Stefania Cesa obtained her bachelor’s degree in Pharnaceutical Chemistry and Technology in 1990 and her PhD in Pharmaceutical Sciences in1995. From 1995 she is a university food chemist researcher, in the Department of Chemistry and Technology of Drug, “Sapienza” University of Rome. The scientific activity was articulated in different interest areas which ranged among studies on functional foods, with the aim to deep the knowledge about the contained bioactive compounds and correlated activities; food waste valorisation, by selective extraction of interesting classes of compounds; development of new analytical techniques, aiming to characterize foods in terms of interesting molecules; evaluation of quality and marker parameters of functional foods. In collaboration with the group of pharmaceutical technology of the same Department, she also studied systems of nanoparticles and liposomes as protective and vehicle systems of bioactive compounds. More recent projects are mainly focalised on sustainability and circular economy aiming to valorise agri-food waste by transforming there in valuable co-products, reducing environmental impact and developing health sustaining systems.

Maria Laura Belladonna is an Associate Professor in cellular and experimental biology at the Pharmacology Section of the Department of Medicine and Surgery, University of Perugia, Italy. She is a biologist with a background in immunopharmacology. Graduated with honors in Drug Chemistry and Technology at the University of Perugia, in 1996 she obtained her PhD degree in Experimental Medicine, discussing a thesis on the immunogenicity acquired by drug- treated tumor antigens. After her PhD she was a research fellow under the supervision of Dr. JC Renauld at the Ludwig Institute for Cancer Research in Brussels, where she acquired great expertise in the production of recombinant heterodimeric cytokines and in the analysis of their signaling. Her areas of expertise are in vitro investigations of the molecular mechanisms underlying immunogenic and tolerogenic responses, with a specific focus on the effects of bioactive molecules released by biomaterials on oxidative stress, osteoclastogenesis, and inflammatory processes. Further research fields are tolerogenic cytokines, the tolerogenic enzyme indoleamine 2,3-dioxygenase 1 (IDO1), and tryptophan metabolism in murine experimental models of autoimmune diseases and in tumors; tumor biomarkers derived from tryptophan metabolism in human Non-Small Cell Lung Cancer (NSCLC); effects of plant-derived bioactive compounds in the regulation of inflammatory processes and osteoclastogenesis; and effects of oxidative stress molecules in bone-damaging diseases. She has contributed to several national and international projects and produced 91 peer-reviewed scientific full papers and 1 book chapter and has translated 7 book chapters. Full papers are included in the “NCBI USA” database and available at the Google Scholar URL https://scholar.google.it/citations?hl=it&user=TJ8gefYAAAAJ.

Dr. Elisabetta Campodoni is now researcher in the Institute of Science, Technology and Sustainability for Ceramics - National Research Council (ISSMC). She obtained her PhD in Materials Science and Technology at the University of Parma in collaboration with ISTEC-CNR of Faenza in 2019 (The project title: Development of the project entitled ‘Design and Development of bio-hybrid multifunctional materials for the regenerative medicine). She is now working on the Development of biocompatible and biomimetic materials (hydrogels, scaffolds and nanoparticles) through a biomineralization and/or blending processes for application in hard and soft tissues regeneration, 3D models in preclinical studies of tumors and degenerative diseases and drug delivery systems. Involved in national and international projects and industrial contracts.